Located at 375-389 Oyster Point Blvd., the property is 5 minutes north of the San Francisco International Airport and surrounded by life science companies. It is also within walking distance of a new ferry terminal that is supposed to open next year. A source familiar with the property and the buyer tells GlobeSt.com that Shorenstein has no near-term plans to redevelop the site – though that is the plan eventually -- and is currently signing multi-year leases for certain buildings within the development.
![]() One of the existing buildings |
"It's a gorgeous site surrounded by water," Kalkin says. "There's not very much underutilized land left [in South San Francisco]; it's a very unique parcel."
The property was not priced when it came to market. Some brokers had suggested the property could garner $120 million, which would have represented a 4% cap rate. At $85 million, the cap rate is closer to 6%. A marketing brochure estimated that the property's year-one NOI (including the marina) for the new owner would be $4.80 million, rising to $4.96 million in year two and $5.4 million in year three.
Recommended For You
![]() Oyster Cove Marina |
Shorenstein Properties made the purchase on behalf of its ninth investment fund, Shorenstein Realty Investors Nine, L.P., a $2.062 billion private commingled fund formed in the spring of 2007. "We believe the property affords a tremendous opportunity for our investors to enjoy stable current income over the next few years with the added long term potential of significant value creation through carefully-planned development at the appropriate time in the market," says Shorenstein chief executive Douglas Shorenstein.
SKS managing partner Paul Stein says the JV is a great follow-up to the duo's development of a new headquarters for FibroGen in Mission Bay, which is slated for completion in late 2008. "We view the redevelopment of Oyster Point as another tremendous opportunity to…develop another life science campus for the Bay Area," he says.
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more inforrmation visit Asset & Logo Licensing.